“…There is an almost unlimited number of different ligands that bind to extracytosolic LBDs, which can thus be used for the development of novel biosensors. These compounds include clinically important compounds such as the neurotransmitters epinephrine ( 77 ), γ-aminobutyric acid (GABA) ( 56 ), histamine ( 78 ) or acetylcholine ( 79 ), antimicrobial peptides ( 80 ), amino acids ( 40 ), organic acids ( 46 ), sugars ( 81 ), fatty acids ( 82 ), quorum-sensing molecules ( 39 ), plant hormones ( 83 ), aromatic hydrocarbons ( 84 ), purines ( 41 ), polyamines ( 25 ), quaternary amines ( 85 ), nitrate ( 86 ), inorganic phosphate ( 87 ), and specific metal cations ( 88 ) or oxanions ( 30 ). The demonstration that extracytosolic LBDs maintain their capacity to sense their ligands over a wide pH range will permit the construction of biosensors that are robust and able to withstand changes in the analyte medium.…”